Immediate Management: Stop Levothyroxine and Investigate for Non-Thyroidal Causes
This patient does not have typical hypothyroidism requiring dose adjustment—the combination of low TSH with low FT4 is biochemically inconsistent with primary hypothyroidism and suggests either central hypothyroidism, assay interference, non-thyroidal illness, or medication non-compliance rather than overtreatment.
Critical First Steps
Immediately Discontinue Current Levothyroxine Therapy
- Stop the 150 mcg levothyroxine immediately until the diagnosis is clarified, as this paradoxical pattern (suppressed TSH with low FT4) indicates the patient is not in a straightforward overtreatment scenario 1.
- Progressive weight loss with these laboratory findings raises concern for serious underlying pathology rather than simple thyroid hormone excess 2.
Repeat Thyroid Function Tests Within 2-4 Weeks
- Confirm the abnormal results with repeat TSH and free T4 measurements, as laboratory error or assay interference can occur 1.
- Measure free T3 levels to complete the thyroid hormone profile 3.
Differential Diagnosis to Investigate
Central (Secondary/Tertiary) Hypothyroidism
- Low TSH with low FT4 suggests pituitary or hypothalamic dysfunction rather than primary thyroid disease 1.
- Evaluate for other pituitary hormone deficiencies (cortisol, prolactin, IGF-1, gonadotropins) 3.
- This is the most likely diagnosis requiring endocrinology referral.
Non-Thyroidal Illness Syndrome
- Severe systemic illness can suppress TSH and thyroid hormones 4.
- Progressive weight loss suggests malignancy, gastrointestinal disease, or other consumptive processes requiring urgent investigation 2.
Medication Non-Compliance or Malabsorption
- Assess adherence to levothyroxine therapy directly with the patient 1.
- Evaluate for malabsorption disorders (celiac disease, inflammatory bowel disease, chronic pancreatitis) that could explain both weight loss and altered thyroid hormone absorption 2, 5.
- Review concomitant medications that may interfere with levothyroxine absorption (iron, calcium, proton pump inhibitors) 1, 4.
Assay Interference
- Heterophile antibodies or biotin supplementation can cause spurious thyroid function test results 5.
- Request alternative assay methods if interference is suspected.
Common Pitfall to Avoid
Do not simply reduce the levothyroxine dose assuming overtreatment. The typical pattern of levothyroxine overtreatment is low TSH with normal-to-high FT4, not low FT4 6. This patient's biochemical profile indicates either:
- She is not absorbing the medication (explaining low FT4 despite adequate dosing)
- She has developed central hypothyroidism (pituitary/hypothalamic failure)
- She has severe non-thyroidal illness
- Laboratory error has occurred
Monitoring Strategy After Diagnosis Clarification
Once the underlying cause is identified:
If Central Hypothyroidism is Confirmed
- Monitor free T4 levels (not TSH) and maintain in the upper half of normal range 1.
- Ensure cortisol deficiency is corrected before initiating thyroid hormone replacement to avoid adrenal crisis 1.
If Primary Hypothyroidism is Reconfirmed
- Restart levothyroxine at an appropriate dose based on body weight (approximately 1.6 mcg/kg for adults, or 1.09 mcg/kg actual body weight for older adults) 1, 7.
- Monitor TSH every 6-8 weeks after dose changes until stable 1.
If Non-Thyroidal Illness is Present
- Treat the underlying condition causing weight loss 4.
- Thyroid hormone replacement is generally not indicated during acute illness unless pre-existing hypothyroidism is documented 4.
The progressive weight loss is the most concerning clinical feature and requires comprehensive evaluation for malignancy, gastrointestinal pathology, endocrine disorders beyond thyroid, and infectious or inflammatory conditions regardless of thyroid status 2, 8.